3-14 | “I felt like I had bugs crawling on the inside of my head”. The highly toxic pills and daily injections that Mary was taking made her vomit, lose her appetite and hallucinate. And it was MSF doctors who were telling her she had to keep on taking them, had to bear all those “side effects” in the hope that she would get well eventually. It took two years. But finally, Mary MARIZANI became the first MSF patient in Zimbabwe to be cured of multidrug resistant tuberculosis. “I had to pass through hell to get to heaven”.
1-2 | MSF calls for rapid registration in countries with high drug-resistant tuberculosis burdenMédecins Sans Frontières (MSF) welcomed the approval by the US Food and Drug Administration of bedaquiline, the first new drug active against tuberculosis (TB) to be registered since 1963.
11-30 | This year the World AIDS Day theme remains the same as that of 2011, "Getting to zero: Zero new HIV infections. Zero discrimination. Zero AIDS related deaths". And the same, big question hangs over it: “Is this too ambitious?” The latest UNAIDS report gives encouraging news that a 50% reduction in the rate of new HIV infections (HIV incidence) has been achieved in 25 low and middle-income countries – more than half in Africa, the region most affected by HIV – between 2001 and 2011. Africa has cut AIDS-related deaths by one third in the past six years.
11-15 | New MSF multinational study of paediatric TB/HIV co-infection confirms crisis of undiagnosed TB among childrenData from the largest-ever multinational cohort of children infected with both tuberculosis (TB) and HIV, released by the international medical humanitarian organisation Médecins Sans Frontières (MSF), shows there is an urgent need for better TB tests for children.
Implementation of new test increases drug-resistant TB diagnosis while shortening treatment initiation time
11-13 | Results from the largest multi-country implementation of the new rapid tuberculosis (TB) diagnostic test reveal an urgent need to address the growing global crisis of drug-resistant TB (DR-TB), according to the international medical humanitarian organisation Médecins Sans Frontières (MSF).